Stock

Captiva Verde Wellness Launches Season 2 of the Miami Padel Club of the Professional Padel League

Retrieved on: 
Monday, April 1, 2024
OTC Markets Group, Health, PPL, Azteca, Bally Sports, Growth, PWR, Social media, Female, News, Stock, Season, International Padel Federation, DAZN, FIP, Qatar Sports Investments, QSI, WPT, Sport, Transaction, San Diego Stingrays

Hosted in the home city of the Miami Padel Club, the first-round championship play will occur from April 2 to April 14 at the Ultra Club in Miami.

Key Points: 
  • Hosted in the home city of the Miami Padel Club, the first-round championship play will occur from April 2 to April 14 at the Ultra Club in Miami.
  • The Miami Padel Club is wholly owned by Captiva Verde.
  • The Miami Padel Club is the only public share trading company in the entire world of Padel.
  • With 25 million active players around the world, all of these players now have an opportunity to become a Miami Padel Club (Captiva Verde) shareholder.

Ultimus LeverPoint Announces New Partnership with WCM Investment Management

Retrieved on: 
Tuesday, April 9, 2024
Stock, Partnership, WCM, Accounting, Data management

CLIFTON PARK, N.Y., April 09, 2024 (GLOBE NEWSWIRE) -- Ultimus LeverPoint Private Fund Solutions (Ultimus), a leading independent provider of full-service, technology-enhanced fund administration, accounting, and investor solutions, is pleased to announce its latest partnership with WCM Investment Management, LLC (WCM), a renowned independent asset management firm based in Laguna Beach, CA, with approximately $90 billion in assets under management.

Key Points: 
  • CLIFTON PARK, N.Y., April 09, 2024 (GLOBE NEWSWIRE) -- Ultimus LeverPoint Private Fund Solutions (Ultimus), a leading independent provider of full-service, technology-enhanced fund administration, accounting, and investor solutions, is pleased to announce its latest partnership with WCM Investment Management, LLC (WCM), a renowned independent asset management firm based in Laguna Beach, CA, with approximately $90 billion in assets under management.
  • In this partnership, Ultimus is providing fund administration for a number of WCM’s private funds, showcasing Ultimus’ ability to offer a unique and efficient fund servicing environment.
  • Recognizing the alignment of values and the potential for a strong partnership, WCM was impressed with Ultimus’ comprehensive, thoughtful response and tailored approach to their needs.
  • The partnership among multiple teams at Ultimus and WCM ensured a seamless transfer of WCM’s limited partners onto the Ultimus platform.

GigaCloud Technology Inc Launches New Service

Retrieved on: 
Thursday, April 4, 2024
Quality control, Growth, Partnership, Procurement, Knowledge, Noble, As a service, GCT, Stock, B2B, Supplier, Marketing, Sales

EL MONTE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce solutions for large parcel merchandise, today announced the launch of its industry-first service, “Branding-as-a-Service” or “BaaS”.

Key Points: 
  • EL MONTE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce solutions for large parcel merchandise, today announced the launch of its industry-first service, “Branding-as-a-Service” or “BaaS”.
  • Designed to enhance the competitiveness of furniture suppliers, the GigaCloud BaaS Program selects and allows Sellers in the B2B GigaCloud Marketplace to sell products under one of the leading American furniture brands, Christopher Knight Home.
  • GigaCloud sets out the product development and quality control standards and oversees the brand management, fulfillment, and marketing and promotion of the branded products.
  • Having Marshall as a member of the GigaCloud team will undoubtedly help propel this program forward as we leverage his vast knowledge and expertise.”

Avicanna Reports Full Year 2023 Audited Financial Results 

Retrieved on: 
Tuesday, April 2, 2024
Cream, Cannabidiol, Cannabinoid, Dravet syndrome, Brazilian Health Regulatory Agency, Interest, Medical cannabis, Seizure, Business, Lennox–Gastaut syndrome, Patient, Pharmacy, Active ingredient, Research, Acquisition, RDC, Ultra, Stock, CBD, Insurance, Health Canada, Bank statement, GMP, Dermatology, TSX, Therapy, Pharmaceutical industry

TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.

Key Points: 
  • TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.
  • Cash used in operations of $1.38 million; an 81% reduction compared to $7.4 million in 2022.
  • “2023 was a tremendous year for Avicanna where we solidified of our leadership position in the Canadian medical cannabis sector through our proprietary products and the launch of MyMedi.ca.
  • We have successfully demonstrated the scalability of our revenues and made significant improvements in our fundamentals while advancing all our business pillars.

Lifeist's CannMart to Offer Roilty Products in Quebec

Retrieved on: 
Wednesday, March 27, 2024
Science, Sale, Stock, SQDC, Cannabis

“Quebec is a very important market for CannMart and with the success of our Rilaxe brand curated products, we knew there was an opportunity to leverage our own lab capabilities to produce and offer new and exciting low-THC, high terpene products in the SQDC,” said Daniel Stern, CEO of CannMart.

Key Points: 
  • “Quebec is a very important market for CannMart and with the success of our Rilaxe brand curated products, we knew there was an opportunity to leverage our own lab capabilities to produce and offer new and exciting low-THC, high terpene products in the SQDC,” said Daniel Stern, CEO of CannMart.
  • “Through our in-house brand Roilty, we can offer specially formulated products such as: Dame des Baies, and Roi Lou Wax in the SQDC.
  • Not only does Roilty offer premium products, but the brand has also earned acclaim at the recent AdCann award for Social Good Campaign of the Year.
  • Building on the success of Rilaxe's initial two concentrate SKUs sold in Quebec, CannMart has collaborated with the SQDC to introduce additional Roilty concentrate SKUs in the province.

Byrna Technologies Reports Fiscal First Quarter 2024 Results

Retrieved on: 
Friday, April 5, 2024
Growth, Gateway Group, CFO, Weapon, OTT, Sale, Acquisition, Stock, DTC, Argentines, Amazon (company), Retirement, Marketing, AOV, Advertising, Television, Mobile phone

ANDOVER, Mass., April 5, 2024 /PRNewswire/ -- Byrna Technologies Inc. ("Byrna" or the "Company") (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today reported select financial results for its fiscal first quarter ("Q1 2024") ended February 29, 2024.

Key Points: 
  • ANDOVER, Mass., April 5, 2024 /PRNewswire/ -- Byrna Technologies Inc. ("Byrna" or the "Company") (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today reported select financial results for its fiscal first quarter ("Q1 2024") ended February 29, 2024.
  • Results compare the 2024 fiscal first quarter ended February 29, 2024 to the 2023 fiscal first quarter ended February 28, 2023 unless otherwise indicated.
  • Net revenue for Q1 2024 was $16.7 million, compared to $8.4 million in the fiscal first quarter of 2023 ("Q1 2023").
  • Byrna CEO Bryan Ganz stated: "2024 has gotten off to an extremely strong start with the Company posting record sales of $16.7 million in Q1, traditionally our slowest quarter.

Sow Good Reports Strong Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Friday, March 22, 2024
Cracker Barrel, Target, Gateway Group, Partnership, Candy, Acquisition, Table, Stock, Net operating loss, Adjustment, SKU, GAAP, OTCQB, Video game

IRVING, Texas, March 22, 2024 (GLOBE NEWSWIRE) -- Sow Good Inc. (OTCQB: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, is reporting financial and operating results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • “Our strong 2023 results reflect our swift momentum and progress as a first mover in the freeze dried candy space,” said Claudia Goldfarb, CEO of Sow Good.
  • Same Year-Ago Quarter
    Revenue in the fourth quarter of 2023 increased significantly to $9.5 million compared to $47.1 thousand in the fourth quarter of 2022.
  • Operating expenses in the fourth quarter of 2023 were $1.6 million compared to $6.4 million in the fourth quarter of 2022.
  • Sow Good will conduct a conference call today at 10:00 A.M. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2023.

IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results

Retrieved on: 
Thursday, March 21, 2024
Quarter, Annual report, Medical Products Agency (Sweden), Parkinson's disease, General counsel, International, Patient, Loan agreement, Research, Webcast, Form 10-K, University, Stock, Senior, Bank statement, TSX, SKU, Investment, Pet, Cryptocurrency

SAINT LAURENT, Quebec, March 21, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the three- and twelve-month periods ended December 31, 2023.

Key Points: 
  • SAINT LAURENT, Quebec, March 21, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the three- and twelve-month periods ended December 31, 2023.
  • Net comprehensive loss was $1.7 million, down from $2.3 million in the fourth quarter of 2022.
  • Operating costs and expenses were $2.4 million for the fourth quarter of 2023, versus $2.7 million for the corresponding three-month period of 2022.
  • IntelGenx will host a conference call to discuss these 2022 fourth quarter and full year financial results today at 8:30 a.m.

Alliance Entertainment Begins Installation of Cost-Saving OPEX Sure Sort X Sortation Technology at Kentucky Warehouse

Retrieved on: 
Thursday, March 21, 2024
Sure, Automation, ROI, OPEX, Sort, Partnership, Electronics, Acquisition, Stock, AEC, Alliance Films, Ecosystem, Music, Video

Utilizing this new Sure Sort X technology will result in annual labor savings of nearly $400,000 for Alliance Entertainment, along with an immediate savings of $460,000 from avoiding retrofitting older sorting technology set to be retired.

Key Points: 
  • Utilizing this new Sure Sort X technology will result in annual labor savings of nearly $400,000 for Alliance Entertainment, along with an immediate savings of $460,000 from avoiding retrofitting older sorting technology set to be retired.
  • The Alliance Entertainment Kentucky warehouse fulfilment center covers 873,000 sq feet, warehousing 31 million units of entertainment product across 330,000 SKUs and ships 52 million units annually.
  • Bruce Ogilvie, Chairman of Alliance Entertainment, commented, “In partnership with OPEX, the expansion of automation capacity at our Kentucky warehouse facility with the acquisition of a Sure Sort X sortation system is a continuation of our margin improvement plan.
  • We continue to innovate and grow our distribution capabilities by futureproofing through the addition of technology and automation.”
    Watch the Sure Sort® X video: https://www.opex.com/wp-content/uploads/2024/03/sure_sort_x-1080p.mp4 .

SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT AND PROVIDES TRADING UPDATE

Retrieved on: 
Wednesday, March 20, 2024
EUR, Partner, Tax, DSR, Offering, Liver disease, FY, Ketel One, KBC, International, Committee, Financial services, 2.0, Cancer, Quality management system, AMERICA, Prospectus, Heart failure, FSMA, Person, European, EQT, LSP, PMA, US FDA, Overload, Stock, Marketing, Transaction, Security (finance)

(ii)   Finalizing the North American pivotal study in recurrent and refractory liver ascites (POSEIDON) towards secondary endpoint readout planned for Q2 2024.

Key Points: 
  • (ii)   Finalizing the North American pivotal study in recurrent and refractory liver ascites (POSEIDON) towards secondary endpoint readout planned for Q2 2024.
  • The Offering shall be structured as a private placement of new shares via an accelerated bookbuilding, which will commence immediately.
  • Trading in Sequana Medical shares on the regulated market of Euronext Brussels will be suspended during the bookbuilding period.
  • Trading in the shares is expected to resume following the publication of the results of the Offering.